Phthalates: the plasticizers that affect testosterone more than estrogen
In many German language texts phthalates are filed under xenoestrogens. The literature does not support that. Their best documented direction of action is antiandrogenic, and it runs through testosterone production, not through the receptor.
I send this text to patients after their appointment, because there is a mix up online that I would otherwise have to untangle by hand every single time. Phthalates are not classic xenoestrogens. Their best documented direction of action is antiandrogenic, and that shifts everything: who is affected, when it counts and where in everyday life it is worth looking more closely.
You type three words into the search bar one evening. Plasticizers, hormones, plastic. The first page tells you phthalates mimic estrogen. The second says the same. So does the third.
Afterwards you look around your bathroom and add up what you have used over the past few years. The next morning the cling film feels different in your hand.
Many people know this pattern. The worry is not the problem, the problem is that it points in the wrong direction.
Because the classification you find there does not hold up against the literature. And that is not a detail. It decides who is rightly addressed, in which phase of life it counts and which four or five everyday habits can actually move anything at all.
So I am not starting with a warning. I am starting with a distinction.
What to expect here
- Why phthalates are not classic estrogen mimics
- Short chain versus long chain: DEHP, DBP, BBP, DINP, DIDP
- The phthalate syndrome of the rat and where its limit lies
- The anogenital distance and the controversy around it
- Why human fetal testis tissue reacted differently
- What has been observed in humans, study by study
- The fat pathway that hardly any page mentions
- House dust and skin as an underrated route
- EFSA, REACH and why agencies word things so carefully
- Three dietary experiments with three different results
- The German time series and what has taken its place
- Four levers, and a paragraph against the urge to control
Environmental factors are a topic for the search for causes. They are not a topic for situations that need to move quickly:
- Undescended testis or a malformation of the urethral opening in a newborn
- Puberty that starts far too early or does not start at all
- Twelve months of trying to conceive without success, earlier for women over 35
- Bleeding after menopause, very heavy or suddenly changed periods
- Acute one sided lower abdominal pain, pain with fever
- Unintended weight loss, visual disturbances, headaches with milk discharge
- Signs of virilisation with a rapid course, for example a deepening voice or strong hair growth
That belongs in gynaecological, andrological or paediatric hands, and before anyone starts thinking about packaging.
The most common thinking error: phthalates are not classic xenoestrogens
Picture two ways of throwing a hormone system off balance.
The first way is a forgery. A molecule looks enough like estrogen to dock onto its receptor. It is a skeleton key in the lock. The lock opens although the real key was never there. That is exactly what classic xenoestrogens do.
The second way is an intervention in the factory. No skeleton key, no lock. Instead, production is throttled. The receptor stays untouched, but less hormone arrives at it. That is exactly what the literature describes for phthalates, and specifically for testosterone.
A team at the US environmental agency around Parks gave pregnant rats DEHP at a high dose and watched the male offspring through sexual development.
Testosterone production fell, the anogenital distance was reduced by 36 percent in the male offspring and not in the females. And the decisive side finding: neither DEHP nor its metabolite MEHP showed binding to the human androgen receptor up to 10 micromolar.
For you that means: nothing here is blocking a receptor. Here hormone production itself is being turned down. That is a different mechanism from an estrogen mimic, which is why the widespread classification is imprecise.
Parks LG, Ostby JS, Lambright CR et al. Toxicol Sci. 2000;58(2):339-349. PMID: 11099646 · DOI: 10.1093/toxsci/58.2.339 [In vivo, rat, in utero]So why does the mix up persist so stubbornly?
Because endocrine disruptor is an umbrella term and not a mechanism. Anything that interferes somewhere in the hormone axes falls under it. The points of attack are completely different. Some substances bind to receptors. Some change breakdown in the liver. Some interfere with synthesis. When a health article describes the group as a whole while picturing the best known example, the special case accidentally becomes the rule.
There is a second reason. Bisphenol A is the prototype of the estrogen mimic and gets mentioned in the same contexts, because both substances come from plastic. Neighbourhood in the packaging then turns into neighbourhood in the mechanism. Chemically that does not hold.
And there is a third reason that honestly belongs here: a grain of laboratory finding out of which the internet made a substance class.
A group around Harris at Brunel University screened a larger number of phthalates for estrogenic activity in a recombinant yeast assay and additionally on estrogen responsive human breast cancer cells.
Some phthalates did show a very weak estrogenic activity, in the order BBP before DBP before DIBP before DEP before DINP. The potency was roughly one million to fifty million times below that of estradiol. DEHP showed no estrogenic activity at all in these assays. And the monoester metabolites tested, which are exactly the forms circulating in the human body, were inactive throughout.
For you that means: the claim is not invented, but it has been torn out of scale. A cell assay with an activity a millionfold weaker than the body's own hormone carries no statement about your hormone balance. The authors write in the same abstract that at the time no data existed on whether this shows up in a living organism at all.
Harris CA, Henttu P, Parker MG, Sumpter JP. Environ Health Perspect. 1997;105(8):802-811. PMID: 9347895 · DOI: 10.1289/ehp.97105802 [In vitro, yeast screen and cell line]If you are looking for the broad overview of the substances that really do act at the estrogen receptor, you will find it in the article on xenoestrogens in everyday life. For men there is a separate version under xenoestrogens in men. Here I am staying with the substance group that is systematically filed in the wrong drawer.
The question is not: are phthalates dangerous or not. The question is: in which direction do they interfere, and when is the system sensitive to that?
For phthalates the literature gives a fairly clear answer. The direction is antiandrogenic. And the most sensitive phase is not the menstrual cycle of an adult woman, it is a short window in pregnancy in which the male anatomy is laid down.
That is why plasticizers are not my first thought in a woman with cycle complaints, and why I do ask about them with a couple who are trying to conceive.
And now you know why this article is needed at all. Not because the topic is underestimated. Because it is overestimated in the wrong place and overlooked in the right one.
What phthalates are, and why there is no single substance
Pick up a shower curtain that is ten years old. It has gone stiff, it is brittle at the edges, and it no longer smells of anything.
That is not ageing in a figurative sense. That is physics. The plasticizer is gone.
Pure PVC is a hard, brittle plastic. To turn it into a shower curtain, a floor covering or an infusion tube, molecules are mixed in that push themselves between the polymer chains and let them glide against each other. These molecules are not chemically attached. They sit in the plastic like water in a sponge.
That is exactly why they leave the plastic. They outgas into room air. They migrate into fat. They collect in house dust. And they enter the body through skin, through the air you breathe and through food.
The second field of use has nothing to do with PVC at all. In cosmetics, short chain phthalates serve as solvents and as fragrance fixatives. They keep the scent on the skin for longer. That is why perfume suddenly turns up in an article about plasticizers, which can look illogical at first glance.
Short chain, medium chain, long chain
The substance group is called phthalic acid esters. Chemically the individual members differ in the length of the attached alcohol chains. This chain length decides almost everything: the use, the routes of uptake and the toxicological assessment.
| Substance | Typical use | Urinary marker | Antiandrogenic evidence |
|---|---|---|---|
| DEP Diethyl phthalate | Fragrance fixative, solvent in cosmetics | MEP | weak |
| DBP Dibutyl phthalate | Paints, adhesives, nail polish, coatings | MBP, MnBP | robust |
| DIBP Diisobutyl phthalate | Replacement for DBP in similar applications | MiBP | weak |
| BBP Butyl benzyl phthalate | Floor coverings, synthetic leather, sealants | MBzP | moderate |
| DEHP Di-2-ethylhexyl phthalate | Flexible PVC of all kinds, medical devices, films | MEHP, MEHHP, MEOHP, MECPP | robust |
| DINP Diisononyl phthalate | Most common DEHP replacement in flexible PVC | MHINP, MCIOP | moderate |
| DIDP Diisodecyl phthalate | Cable sheathing, heat resistant flexible PVC | MCINP | assessed separately, liver effects |
Why metabolites are measured and not the substance
Phthalates do not stay long. The body splits them quickly into monoesters, oxidises them further and excretes them through urine. The half lives are in the range of hours to a few days.
That is good news and awkward news at the same time.
The good part: there is no depot. Unlike heavy metals or the long lived PFAS, no store fills up over decades. When the intake stops, the values fall within days.
The awkward part: a single urine sample essentially tells you something about the last one to two days. It is a snapshot, not a life balance. That is exactly why the good studies work with repeated samples, and exactly why I am reserved about a single commercial phthalate measurement. What is actually informative in hormone diagnostics and what is not is something I have written down in more detail in the article on hormone testing in women.
The common idea goes like this: toxins accumulate, and at some point the barrel is full.
For phthalates that image does not apply. There is no barrel here. There is a tap that runs a little every day. What counts is not the sum of the last few years, it is the daily resupply during a sensitive phase.
That takes weight off and sharpens the focus at the same time. It takes weight off because past years do not carry forward as a legacy burden. It sharpens the focus because it directs attention to where it belongs: pregnancy, breastfeeding and the first years of life.
And now you know why an article about phthalates can never talk about a single substance. DEP in perfume and DEHP in the fat line of a dairy share a surname and have very different risk profiles.
The phthalate syndrome: what the rat studies show and where their limit lies
There is a term in toxicology that turns up in health articles almost always without a footnote: the phthalate syndrome.
It sounds like a diagnosis. It is not one. It is the description of a pattern of findings in male rat offspring.
Foster, at the US National Institute of Environmental Health Sciences, summarised what DBP, DEHP and BBP do in rats when the mothers receive them during gestation.
The pattern includes malformations of the epididymis, vas deferens, seminal vesicles and prostate, plus hypospadias, undescended testes, testicular damage, retained nipple anlagen and a shortened anogenital distance. The cause is a marked reduction in fetal testosterone production during the critical developmental window, together with a downregulation of Insl3, which may explain the undescended testes.
For you that means: the pattern is real and well reproduced. Foster himself writes, however, that parallels to the human testicular dysgenesis syndrome exist without a cause and effect relationship being established for humans.
Foster PMD. Int J Androl. 2006;29(1):140-147. PMID: 16102138 · DOI: 10.1111/j.1365-2605.2005.00563.x [Mechanism Review, rodent data]Why a short time window in pregnancy decides everything
- In a narrowly defined section of pregnancy, the fetal testis starts producing testosterone itself. The specialist literature calls this section the masculinisation programming window.
- How much testosterone is present in this window strongly shapes how the genitals, epididymis, vas deferens and prostate are laid down. It is a set of building instructions that is read out only once.
- In the rat model, phthalates interfere at exactly that point. They lower the enzymes and transport proteins of steroid synthesis in the Leydig cell, in other words the tools of the factory.
- The androgen receptor remains untouched in the process. In the binding assay, no affinity of DEHP or MEHP for the human androgen receptor was found up to 10 micromolar.
- Because the building instructions are read out only once, a deficit in this window leaves lasting structural features in the animal model. The same dose in a fully grown animal does not carry the same meaning.
Important for context: the dose in the Parks work was 750 milligrams per kilogram of body weight per day. Estimated dietary intake in humans according to EFSA averages 0.9 to 7.2 micrograms per kilogram per day. That is several orders of magnitude apart, and it belongs in every sentence that cites this study.
I write this so explicitly because health articles regularly make the jump that is not permitted here. A rodent finding becomes a statement about boys. A high dose becomes a statement about shower curtains.
Both are an overreach, and both damage the topic. Whoever exaggerates makes a legitimate concern look implausible.
An animal experiment does not answer the question of whether a substance harms you. It answers the question of whether a substance is capable of interfering with a particular system at all, and where that interference starts.
That information is valuable. It tells you where to look in humans. It does not tell you what you will find there.
That is exactly why the next section continues, and exactly why it gets uncomfortable there.
And now you know why the phrase phthalate syndrome always needs a footnote in a text about humans. Without it, a clean observation in the rat turns into an unclean claim about your child.
The anogenital distance in newborns and the honest controversy
If you have read this far, you are waiting for the point where it is about humans. Here it is. And it is more contradictory than either camp online admits.
The anogenital distance is a measurement between the anus and the genitals. In animal research it has been a mirror for decades of how much androgen action arrived in the womb. In male animals it is on average about twice as large as in females. So it is an obvious thing to measure in humans too.
A team around Swan measured the anogenital distance in 134 boys aged 2 to 36 months and linked it with nine phthalate metabolites from prenatal urine samples of the mothers.
Four metabolites were inversely associated with the weight adjusted index. For the highest versus the lowest MBP quartile, the odds ratio for a shorter than expected index was 10.2, with a confidence interval from 2.5 to 42.2.
For you that means: the signal is strong, the precision is not. A confidence interval running from 2.5 to over 42 is a hint and not a measurement. Eighty-five children with a prenatal urine sample is few, and the measurement was taken once.
Swan SH, Main KM, Liu F et al. Environ Health Perspect. 2005;113(8):1056-1061. PMID: 16079079 · DOI: 10.1289/ehp.8100 [Cohort, newborns and infants]In the TIDES cohort, phthalate metabolites were determined in first trimester urine and linked with genital measurements at birth, in 366 boys and 373 girls.
Three DEHP metabolites were significantly inversely associated with both distance measures in the boys. For the anoscrotal distance the estimates were minus 1.12 for MEHP, minus 1.43 for MEOHP and minus 1.28 for MEHHP. In the girls no association was found with any metabolite.
For you that means: the effect can be reproduced in a large cohort, and it is small. A good millimetre on average, calculated across hundreds of children. The authors themselves name as limitations that only one urine sample was available and that the centres differed markedly.
Swan SH, Sathyanarayana S, Barrett ES et al. Hum Reprod. 2015;30(4):963-972. PMID: 25697839 · DOI: 10.1093/humrep/deu363 [Cohort, prospective, n=753]The direction is not the same everywhere
A prospective cohort from South Carolina examined second trimester urine from 380 mothers and then measured 171 boys and 128 girls.
MEHP was inversely associated with the anopenile distance, at minus 1.57 millimetres with a p value of 0.02. For the sum of the DBP metabolites, by contrast, the anoscrotal distance was longer, at plus 0.99 millimetres with a p value of 0.04.
That is uncomfortable, and that is exactly why it belongs here. When an endpoint points one way for one substance and the other way for another, the picture is not as closed as it sounds in summaries.
Wenzel AG, Bloom MS, Butts CD et al. Environ Int. 2018;110:61-70. PMID: 29097052 · DOI: 10.1016/j.envint.2017.10.007 [Cohort, prospective]The point where it really gets uncomfortable
Now comes the finding that did not appear in the German language overviews I read for this article. It is the most important one in this section.
Two independent research groups have transplanted human fetal testis tissue into rodents and then given phthalate. The set up is elegant, because it places the human tissue in a living environment instead of a petri dish.
A group around Mitchell at the Centre for Reproductive Health of the University of Edinburgh transplanted human fetal testis tissue from weeks 14 to 20 of pregnancy into castrated nude mice and gave the host animals DBP or monobutyl phthalate.
Serum testosterone was 0.56 versus 0.64 nanograms per millilitre, seminal vesicle weight 67.2 versus 81.9 milligrams, in both cases without statistical significance. Rat tissue in the same model, by contrast, showed a clear reduction in testosterone, seminal vesicle weight and the expression of Cyp11a1 and StAR.
For you that means: the positive control worked. The human tissue still did not react.
Mitchell RT, Childs AJ, Anderson RA et al. J Clin Endocrinol Metab. 2012;97(3):E341-E348. PMID: 22238399 · DOI: 10.1210/jc.2011-2411 [In vivo, xenograft, n=12]A group around Heger at Brown University transplanted fetal testis tissue from rat, mouse and human into immunodeficient rodents and gave phthalate at several dose levels.
Multinucleated germ cells appeared in rat and mouse tissue, but only the rat showed suppressed steroidogenesis. Multinucleated germ cells also appeared in the human tissue, yet across the entire dose range there was no reduced expression of the genes that control fetal testosterone biosynthesis.
For you that means: second research group, same result. And one detail that no page quotes along with it: the germ cells of the human tissue did change. The only thing that did not react was the hormone axis.
Heger NE, Hall SJ, Sandrof MA et al. Environ Health Perspect. 2012;120(8):1137-1143. PMID: 22511013 · DOI: 10.1289/ehp.1104711 [In vivo, xenograft]If that were everything, I would write here: the rat model does not transfer, topic closed.
But it is not everything.
A group around Desdoits-Lethimonier at the French research institute INSERM in Rennes cultured explants of adult human testis together with DEHP or MEHP, plus a human adrenocortical cell line.
In both models testosterone production fell significantly. The effect was specific to steroid synthesis: INSL3 production by the Leydig cells, inhibin B production by the Sertoli cells and germ cell apoptosis remained unchanged. The authors place the concentrations used in an order of magnitude that corresponds to the exposures reported in the literature for men.
For you that means: the adult human testis does react in the laboratory. That does not make the picture simpler, it makes it more differentiated.
Desdoits-Lethimonier C, Albert O, Le Bizec B et al. Hum Reprod. 2012;27(5):1451-1459. PMID: 22402212 · DOI: 10.1093/humrep/des069 [In vitro, organ culture and cell line]Three levels, three answers
- Fetal rat testis
- Clear reduction in testosterone production, reproduced across many studies. High doses.
- Fetal human testis as a xenograft
- No reduction in steroidogenesis in two independent studies, although the rat control reacted in the same model. Changes in the germ cells, however, were seen.
- Adult human testis in organ culture
- Significant inhibition of testosterone production, specific to steroid synthesis.
Honest summary: the species question is open. The signal in the cohort data cannot be explained away, and the transfer of the rat finding to human pregnancy cannot be proven. Leaving out either of these two sides turns it into a story instead of an assessment.
I write this explicitly, because I know how this section lands with new parents.
The anogenital distance is a research measure for group comparisons. The differences in the studies are around one millimetre on average across hundreds of children. In an individual child nothing can be read from it, and the spread among healthy children is many times larger than the described effect. Even between the study centres of the TIDES cohort there were clear differences in measurement.
And the objection that carries the most weight in this field: the anogenital distance is a surrogate measure. Whether a group difference of about one millimetre carries any later health meaning for an individual child is not settled. There is no threshold above which a value counts as abnormal, and no study that predicts a later disease from this measure. That is why the endpoint is contested among specialists, and why it stands here with that limitation.
What does belong with the paediatrician are visible findings: a testis that cannot be palpated, a malformation of the urethral opening, a conspicuous genital development. That is what the routine child health checks are for. Please do not rely on them alone. A testis can ascend again even after a normal early examination, and current recommendations say that an undescended testis should be treated by the first birthday. If you notice something between two appointments, take it there and do not wait for the next scheduled check.
One thing tolerates no delay. If the genitals of a newborn cannot be clearly assigned, that needs medical assessment the same day. One of the possible causes is congenital adrenal hyperplasia, which can trigger a salt wasting crisis in the first weeks of life. If a newborn also shows poor feeding, vomiting, weight loss or listlessness, that is an emergency. Then it is the emergency number 112, not the next practice appointment.
An open contradiction in the literature is not a sign that science is failing. It is a sign that several groups have looked independently of each other.
My position on this is uncomfortable for both camps. I treat phthalates neither as a proven cause nor as a closed topic. I treat them as a plausible influence, limited in its magnitude, that deserves more attention in certain phases of life than in others.
That is less catchy than a headline. But it is what the data support.
And now you know why I speak more slowly about this topic in consultation than about others. Because both exaggerations, playing it down and dramatising it, fail at the same point: the species question.
What has been observed in humans, study by study
Up to here it was about mechanisms. Now it is about people, with the study design named alongside, because in this field the design is half the statement.
There is one piece of work that stands as a roof over everything. It comes neither from activism nor from industry, but from the scientific environment of the US environmental agency: two of the four authors work there, the other two at Brown University and the University of Michigan. Important for context: it is a publication by these specialists and not an official statement by the agency. They write that into the paper themselves.
A team around Radke systematically searched PubMed, Web of Science and Toxline for six phthalates and had two independent assessors rate the risk of bias and sensitivity of every single study.
The result is a gradation rather than a blanket statement: robust evidence for DEHP and DBP, moderate for DINP and BBP, slight for DIBP and DEP. For DIBP the authors explicitly attribute the weaker rating to fewer studies and lower exposures, for DEP by contrast to a genuinely lower antiandrogenic effect in animal experiments.
For you that means: not all phthalates are the same, and the differences have two quite distinct reasons. Sometimes data are missing, sometimes the effect is missing. That is not the same thing.
Radke EG, Braun JM, Meeker JD, Cooper GS. Environ Int. 2018;121(Pt 1):764-793. PMID: 30336412 · DOI: 10.1016/j.envint.2018.07.029 [Systematic Review, human data]Testosterone
One single number circulates online here. Twenty two percent less testosterone, supposedly from Rochester in 2007. I tried to trace it to a specific publication and did not succeed. Without a reference quantity and without a study design I do not cite it. Instead, two pieces of work that bring their own numbers.
Meeker and Ferguson analysed the US health survey NHANES 2011 to 2012, 13 phthalate metabolites in urine against total testosterone in serum, separated by sex and age group.
In boys aged 6 to 12 years, an increase in DEHP metabolites by one interquartile range was associated with a 29 percent reduction in testosterone, confidence interval 6 to 47. In adult men, significant or suggestive inverse associations were found only in the group aged 40 to 60.
For you that means: a cross section cannot prove a direction. Low testosterone and high phthalate values can both follow from the same lifestyle. What remains striking is that of all groups, the youngest showed the clearest association.
Meeker JD, Ferguson KK. J Clin Endocrinol Metab. 2014;99(11):4346-4352. PMID: 25121464 · DOI: 10.1210/jc.2014-2555 [Cohort, cross section NHANES]A team around Pan compared 74 employees of a PVC flooring factory with 63 employees of a construction company, matched for age and smoking status.
The exposure was extreme: MEHP was 565.7 versus 5.7 micrograms per gram of creatinine, so roughly a hundredfold difference. Free testosterone was 8.4 versus 9.7, with a p value of 0.019. As the total phthalate score rose, free testosterone fell significantly.
For you that means: at a hundredfold exposure, the difference in testosterone was moderate. This relation belongs in every text about plasticizers, otherwise panic arises over the shower curtain dose.
Pan G, Hanaoka T, Yoshimura M et al. Environ Health Perspect. 2006;114(11):1643-1648. PMID: 17107847 · DOI: 10.1289/ehp.9016 [Cohort, cross section, occupational exposure]One practical note on this: if your work involves flexible PVC, plastics processing, paints or adhesives, the route is not a private practice but occupational health care. Your company doctor can look at the risk assessment for your workplace, and occupational biomonitoring runs through the responsible statutory accident insurance institution. That is also the route through which an occupational exposure is recorded in legal terms.
If your testosterone value has already been measured as low, plasticizers are not the first question. The more common reasons are described in the article on testosterone deficiency in men, and if the long term population trend interests you, you will find it under testosterone is falling worldwide.
Semen quality
This is where it gets interesting, because of all substances the one with the strongest animal data was not the one that stood out.
A team around Hauser at the Harvard School of Public Health studied 463 male partners of subfertile couples and linked semen parameters with phthalate metabolites from a spot urine sample.
For MBP a dose response relationship with low sperm concentration was found, odds ratios across the quartiles of 1.00 to 3.1 to 2.5 to 3.3 with a p value for trend of 0.04. For the three DEHP metabolites, by contrast, no association was found, and none for monoethyl and monomethyl phthalate either.
For you that means: anyone who treats phthalates as one single group loses exactly this information. DBP stood out, DEHP did not.
Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Epidemiology. 2006;17(6):682-691. PMID: 17003688 · DOI: 10.1097/01.ede.0000235996.89953.d7 [Cohort, clinic, subfertile couples]Everything else on semen quality, from heat through micronutrients to testing intervals, is in the separate article on semen quality and fertility. I am not repeating it here.
Course of pregnancy
A team around Welch at the US National Institute of Environmental Health Sciences pooled individual data from 16 US cohorts with births between 1983 and 2018.
Among 6,045 participants and 539 preterm births, the odds ratios per interquartile range lay between 1.12 and 1.16, with confidence intervals that repeatedly touch one. A model calculation estimated that a hypothetical 50 percent reduction in the mixture concentration could prevent about 11.1 preterm births out of around 90 preterm births per 1,000 live births.
For you that means: the second number comes from a model calculation with causal assumptions, and the authors say so themselves. It is a projection, not a measurement.
Welch BM, Keil AP, Buckley JP et al. JAMA Pediatr. 2022;176(9):895-905. PMID: 35816333 · DOI: 10.1001/jamapediatrics.2022.2252 [Cohort, pooled, n=6,045]Child development and metabolism
Two lines of observation run alongside the androgen axis. I present them as a hint, not as an established finding.
A team around Factor-Litvak at Columbia University in New York followed 328 mother and child pairs and tested the children at the age of seven.
Full scale IQ was inversely associated with DnBP and DiBP, at minus 2.69 points per log unit for both substances. In the highest versus the lowest quartile, the value was 6.7 and 7.6 points lower respectively.
For you that means: a single cohort at one site with strong social confounding. Strong as a hint, not sufficient as proof.
Factor-Litvak P, Insel B, Calafat AM et al. PLoS One. 2014;9(12):e114003. PMID: 25493564 · DOI: 10.1371/journal.pone.0114003 [Cohort, longitudinal]A team around Stahlhut at the University of Rochester studied adult US men from NHANES 1999 to 2002.
Four metabolites were associated with a larger waist circumference and three with a higher HOMA index. After additional adjustment for kidney and liver function the estimates fell, but remained significant with one exception.
For you that means: the direction is open. Excess weight changes diet and with it exposure. The association can run in both directions, and that is why I cite it as a hypothesis and not as a causal chain.
Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Environ Health Perspect. 2007;115(6):876-882. PMID: 17589594 · DOI: 10.1289/ehp.9882 [Cohort, cross section NHANES]And what about women?
Patients ask me this question with good reason, because the whole article up to here sounds very male.
The honest answer: for the menstrual cycle, PMS and estrogen dominance there are no solid data on phthalates in this set of sources. There are two lines, and both need to be read carefully.
A team around Messerlian at the Harvard T.H. Chan School of Public Health studied 215 women at a fertility centre and linked phthalate metabolites with the antral follicle count on cycle day three.
Compared with the lowest DEHP sum quartile, the mean follicle count was 24 percent lower in the second quartile, 19 percent lower in the third and 14 percent lower in the fourth. In absolute terms: 14.2 follicles in the first versus 10.7 in the second quartile.
For you that means two things. First, the dose response relationship is not rising, the strongest association was in the second quartile. Second, the authors themselves emphasise that this cannot be transferred to women without fertility problems.
Messerlian C, Souter I, Gaskins AJ et al. Hum Reprod. 2016;31(1):75-83. PMID: 26573529 · DOI: 10.1093/humrep/dev292 [Cohort, prospective, fertility centre]The second line is a narrative review on ovarian ageing caused by environmental pollutants. For persistent and non persistent substances it describes an overall increased risk of a lower ovarian reserve, irregular menstrual cycles and an earlier age at menopause, while in the same breath naming inconsistent results and differences between human and animal studies. I cite it as a frame, never for a single number.
If you are a woman looking for environmental factors behind cycle complaints, phthalates are not the most obvious trail. They interfere with an axis that is not at the centre for you.
Two other directions are closer. The first are substances that really do act at the estrogen receptor, and that includes the mould toxin zearalenone, a well documented mycoestrogen. How that fits together is described in the article on zearalenone and hormones. The second is the question of how well your body breaks estrogen down again, and you can read more on that under lowering estrogen naturally through the liver.
And one sentence that has to appear in every environmental article: none of this means that every hormonal disturbance has an environmental cause.
And now you know why I ask different questions in the history depending on who is sitting in front of me. Not because men and women have different amounts of plastic in their daily lives, but because the axis that phthalates interfere with plays a different role in each.
Where it comes from: fat, fragrance, flooring, dust, clinic
Most guides start here. I only start here, because the question of the source only makes sense once it is clear which substance counts at all.
And there is one pathway that almost never appears in German texts, although it is the most important one.
Fat is the carrier
Phthalates are fat loving. They migrate to where the fat is. And because in food processing fat passes through tubes, over seals and along conveyor belts made of flexible PVC at many points, the burden often does not arise in the retail packaging but long before it.
A team around Serrano reviewed 17 studies with phthalate measurements in food, three epidemiological association studies and three interventions.
Consistently high DEHP concentrations from 300 micrograms per kilogram upwards were found in poultry, edible oils and cream containing dairy products. DEP was below 50 micrograms per kilogram in all food groups. Estimated DEHP intake on a typical diet was 5.7 micrograms per kilogram per day in women of childbearing age, 8.1 in adolescents and 42.1 in infants. A diet high in meat and dairy doubled the intake, dairy products were the largest single contributor.
For you that means: the decisive lever is not plastic in general, it is the combination of fat and flexible PVC. That is exactly why it does little to replace a dry pasta packet, and more not to pour hot fat into plastic.
Serrano SE, Braun J, Trasande L, Dills R, Sathyanarayana S. Environ Health. 2014;13(1):43. PMID: 24894065 · DOI: 10.1186/1476-069X-13-43 [Mechanism Review, food monitoring]Fragrance is the second lever
A team around Duty at the Harvard School of Public Health surveyed 406 men about their use of cologne, aftershave, lotions, hair products and deodorants and measured phthalate monoesters in urine at the same time.
Those who had used cologne or aftershave in the previous 48 hours had median MEP values of 265 and 266 nanograms per millilitre respectively, compared with 108 and 133 in non users. For each additional product type used, MEP rose by 33 percent. Lotion use, conversely, was associated with lower levels of MBP, MBzP and MEHP.
For you that means: fragranced products are the clearest single lever for DEP. But the same study also shows that no rule for all cosmetics can be derived from it, because with lotions the opposite direction appeared.
Duty SM, Ackerman RM, Calafat AM, Hauser R. Environ Health Perspect. 2005;113(11):1530-1535. PMID: 16263507 · DOI: 10.1289/ehp.8083 [Cohort, cross section with questionnaire]Part of the context: DEP of all things, the fragrance phthalate, is the substance with the weakest documented antiandrogenic direction in that systematic review. The marker rises clearly, the assigned evidence is the thinnest in the whole set. Saying both at once is uncomfortable and still correct.
The home, the dust and the skin
This route is the most underrated one, and it changes the priority list.
A team around Bekö at the Technical University of Denmark measured phthalate metabolites in urine in 431 children aged 3 to 6 years and compared the total intake calculated from that with the estimated intake through dust, indoor air and skin at home and in daycare.
Indoor air and dust explained around 100 percent of total intake for DEP, around 50 percent for DiBP and around 15 percent for DnBP, with uptake through the skin from the gas phase being the main route. For BBzP and DEHP, by contrast, over 90 percent came from other sources. The highest total intake was for DEHP with a median of 4.42 micrograms per kilogram per day.
For you that means: with the short chain phthalates the largest part comes from room air, and specifically through the skin. Not through the mouth. That is why damp mopping and airing out in a room with old flexible PVC can do more than perfectionism while shopping.
Bekö G, Weschler CJ, Langer S et al. PLoS One. 2013;8(4):e62442. PMID: 23626820 · DOI: 10.1371/journal.pone.0062442 [Cohort, biomonitoring and modelling]Flexible PVC in the home mainly means: old floor coverings, synthetic leather, shower curtains, coated wallpaper, some cable sheathing. And here European regulation is good news with a gap. It applies to articles newly placed on the market. The floor covering that has been in the flat since 1998 was never covered by it.
Medical devices
Flexible PVC is widespread in the clinic, in tubes, bags and catheters. That can be measured.
A team around Pinguet at the university hospital of Clermont-Ferrand developed a measurement method for DEHP and 17 further plasticizer metabolites and applied it to patients in a neonatal intensive care unit.
The metabolites were found with a median detection frequency of 95.2 percent, across a range of 12.5 to 100 percent.
For you that means: the exposure is real and documented. But explicitly no recommendation for parents follows from it. Whether a line is placed and with which material is a weighing of benefit against burden, and it belongs in the hands of the treating doctors. Putting a necessary treatment in doubt because of this question would be the wrong conclusion.
Pinguet J, Kerckhove N, Eljezi T et al. Talanta. 2019;198:377-389. PMID: 30876575 · DOI: 10.1016/j.talanta.2019.01.115 [Cohort, biomonitoring, neonatology]The common idea goes like this: plastic is the problem, so get rid of the plastic.
The data say something more precise. The problem is not plastic, it is the meeting of fat and flexible PVC, and the room air in a home with soft plastic.
That is good news, because it makes the task smaller. You do not have to rebuild your whole life. You can start at two or three points where something is actually at stake.
And now you know why questions about your job, your floor covering and the age of your flat come up in my history taking. Not out of curiosity, but because they say more about the daily resupply than a look in the fridge.
What the agencies say, and why they say it that way
This is where many conversations fall apart. One side says: the agencies have checked it, so everything is fine. The other side says: the agencies are playing it down.
Both fall short, and once you read what the assessments actually say, you understand why.
The responsible panel of the European Food Safety Authority updated the risk assessment of DBP, BBP, DEHP, DINP and DIDP for food contact materials in 2019.
For DBP, BBP, DEHP and DINP a provisional group limit of 50 micrograms per kilogram of body weight per day was set, expressed as DEHP equivalent. The reasoning is stated explicitly in the document: these four share the same mode of action, namely the reduction of fetal testosterone. DIDP was handled separately with its own value of 150, justified by liver effects rather than reproductive toxicity.
For you that means: the agency grouping is the strongest official evidence that the antiandrogenic direction is the common denominator. And it is the answer to the question of why DIDP is treated differently from the others.
EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). EFSA Journal. 2019;17(12):e05838. DOI: 10.2903/j.efsa.2019.5838 [Agency Document, EFSA] [Guideline]The same document contains the order of magnitude that almost never appears in health articles. Estimated aggregated dietary exposure for the group was 0.9 to 7.2 micrograms per kilogram per day at mean consumption and 1.6 to 11.7 at high consumption. That corresponds to roughly 1.8 to 23 percent of the group limit.
So the average lies clearly below it. That belongs in the text just as much as everything else. And in the same breath belongs the fact that average is not everyone. The Danish study found a daily intake above the limit of the time in 22 and 23 of 431 children respectively, and cumulatively across three substances in as many as 30 percent of the children.
Annex XVII of the European chemicals regulation REACH lays down in entry 51 that articles containing DEHP, DBP, BBP or DIBP at a concentration of 0.1 percent or more of the plasticised material may not be placed on the market.
The regulation extended the scope beyond toys and childcare articles to plasticised articles in general and newly included DIBP. For toys and childcare articles as a substance or mixture it has applied since 7 January 2019, for placing the articles on the market since 7 July 2020. Entry 52 additionally restricts DINP, DIDP and DNOP in toys and childcare articles that can be placed in the mouth.
For you that means: new goods in European retail are regulated for these substances. Old floor coverings, old shower curtains and imported goods outside EU retail are not. That is exactly why the home is often the more relevant place than the supermarket.
Commission Regulation (EU) 2018/2005 of 17 December 2018 amending Annex XVII to Regulation (EC) No 1907/2006 (REACH), entry 51. Official Journal of the European Union. [Agency Document, EU legal act] [Guideline]In 2015 the Endocrine Society published its second scientific statement on endocrine disrupting chemicals, a document of more than a hundred pages covering seven topic areas.
It describes non monotonic dose response curves, effects in the low dose range and the particular vulnerability during developmental windows as endocrinological basic principles. Causal links between exposure and disease are supported by animal models and are compatible with correlative human data. In the same document the society explicitly continues to urge caution in inferring causality in humans.
For you that means: the largest endocrinology society in the world considers endocrine disruptors clinically relevant and says in the same paragraph that causality in humans is not proven. This article carries exactly that double statement.
Gore AC, Chappell VA, Fenton SE et al. Endocr Rev. 2015;36(6):E1-E150. PMID: 26544531 · DOI: 10.1210/er.2015-1010 [Consensus Guideline, Endocrine Society] [Guideline]Agencies assess substances. Clinicians assess people. The first need causality, the second work with probabilities. Both are legitimate, and neither replaces the other.
How I explain the caution of the regulatory agencies to myselfI write this without resentment. A regulatory agency that bans on suspicion loses its foundation. A physician who only acts once causality is proven waits a lifetime with most chronic complaints.
The same goes for routine gynaecological and andrological care. A thorough exposure history takes time, and in a consultation with a tight time frame that time is often not there. That is not negligence, it is a question of focus areas and time budgets. The gynaecological and andrological assessment remains the foundation. The environmental perspective comes on top, not in its place.
A limit value is not a border between healthy and ill. It is an administrative decision under uncertainty, with safety factors, with assumptions and with the state of knowledge of the time.
That is why the sentence that a value lies below the limit is reassuring and limited at the same time. It says: by today's assessment this is acceptable. It does not say: nothing is happening here.
And the reverse holds equally. An exceedance is not damage, it is a reason to take a closer look.
And now you know why I do not bash the agencies on the subject of endocrine disruptors. The EFSA assessment of 2019 is the strongest argument this article has. It grouped the four substances together because they act in the same direction.
What has measurably changed something, and what has not
Now the question that probably matters most to you. Does it do anything at all if you change something?
There are three intervention studies in humans on this. They have three different results. I am showing you all three, because the practical part would otherwise be dishonest.
A team at the Silent Spring Institute around Rudel followed 20 people from five families who reported eating canned and packaged food frequently. For three days there was exclusively fresh food without cans and without plastic packaging, before and after that the usual diet.
The geometric means of the DEHP metabolites fell by 53 to 56 percent, the maximum values by 93 to 96 percent. MEHHP fell on average from 57 to 25 nanograms per millilitre.
For you that means: the lever can be very effective. What is remarkable is the distribution. The peak values fell far more than the means. So the intervention mainly took away the outliers, and outliers arise at individual points, not everywhere.
Rudel RA, Gray JM, Engel CL et al. Environ Health Perspect. 2011;119(7):914-920. PMID: 21450549 · DOI: 10.1289/ehp.1003170 [Intervention, n=20, no control arm]Same idea, the opposite as a result
A team around Sathyanarayana at the University of Washington randomised ten families. One arm received a fully provided replacement diet for five days, the other only written recommendations.
In the intervention arm the DEHP metabolites rose from a median of 283.7 to 7,027.5 nanomoles per gram, with a p value below 0.0001. Analysis of the study ingredients showed DEHP concentrations of 21,400 nanograms per gram in ground coriander and 673 nanograms per gram in the milk. Estimated daily intake in the children in this arm was above the reference values of the US environmental agency and EFSA.
This study has to be in every honest text about plasticizers. Fresh and unpackaged does not automatically mean less, if the burden already arose in the processing chain. And it shows how little a consumer can decide about it.
Sathyanarayana S, Alcedo G, Saelens BE et al. J Expo Sci Environ Epidemiol. 2013;23(4):378-384. PMID: 23443238 · DOI: 10.1038/jes.2013.9 [RCT, n=10 families]A team around Barrett at the University of Rochester gave ten pregnant women on low incomes a provided diet of mostly fresh, organically produced food for three days.
The metabolite concentrations did not change appreciably. For the DEHP sum no significant difference was found across the three time periods and no reduction compared with baseline. In the interviews the participants said that outside the study they were not motivated to change their diet because of chemical exposures.
For you that means: the authors themselves conclude that dietary appeals are of little use as a population measure and that regulation in processing and packaging is the stronger lever. That is a sentence that takes weight off, and it may stand as it is.
Barrett ES, Velez M, Qiu X, Chen SR. Matern Child Health J. 2015;19(9):1936-1942. PMID: 25652062 · DOI: 10.1007/s10995-015-1707-0 [Intervention, pilot study, n=10]It is not the packaging on the shelf that decides, it is the point where fat meets flexible PVC. The lever works where the source really is the packaging, and it does not work when the burden already arose during processing. That is the most honest sentence the data allow.
The German time series, and what has taken its place
Now comes the calmest finding of the whole topic, and it did not appear in the German language guides I read for this article.
A team around Koch at the Institute for Prevention and Occupational Medicine of the DGUV in Bochum, together with the German Environment Agency, analysed a total of 1,162 twenty four hour urine samples from the years 1988 to 2015 for 21 phthalate metabolites.
For the metabolites of DEHP, DnBP and BBzP there was a roughly tenfold decline in median values from the peaks in the late eighties and early nineties through to 2015. Before 2002, health based guidance values were exceeded for DnBP in 27.2 percent and for DEHP in 2.3 percent of samples, in more recent samples DEHP was still exceeded in 1.0 percent. For DiBP the decline set in later, possibly because of the later classification as toxic for reproduction in 2009.
For you that means: European regulation has measurably changed something in Germany. That is not a small matter, it is a rare case in which a political decision can be traced in the urine of a population.
Koch HM, Rüther M, Schütze A et al. Int J Hyg Environ Health. 2017;220(2 Pt A):130-141. PMID: 27863804 · DOI: 10.1016/j.ijheh.2016.11.003 [Cohort, biomonitoring time series, n=1,162]The substitutes do the same thing
In 2021 the German Environment Agency, together with the Bochum institute, described the German human biomonitoring system using plasticizers as an example.
The result in one sentence: the burden from DEHP, DiBP, DnBP and BBzP has fallen considerably, while the burden from the substitutes DPHP, DEHTP and DINCH has risen significantly. The youngest children showed the highest levels of most of the plasticizers studied, in part with DiBP and DnBP values still above the guidance values. A cumulative risk assessment across four endocrine active phthalates shows a still relevant combined burden in many young children.
Two messages are contained in that. First: young children are the most heavily exposed group in German biomonitoring. That is why the notes that follow are written for families. Second: phthalate free is a statement about a substance group, not a safety statement.
Lemke N, Murawski A, Lange R et al. Int J Hyg Environ Health. 2021;236:113780. PMID: 34126298 · DOI: 10.1016/j.ijheh.2021.113780 [Agency Document, German Environment Agency]There is a strange asymmetry in this field. The bad news is shared everywhere, the good news almost never.
The burden from the classic phthalates in Germany has fallen by roughly a factor of ten. That is one of the best pieces of news environmental medicine has had to offer in the last thirty years.
It is not a reason to close the topic, because the substitutes are rising and are less well studied. But it is a very good reason to talk about it without panic.
And now you know why I do not advise clearing out the whole flat on this topic. The largest part of the work has already been done at a point where you could not have done it yourself.
What I make of this in practice, without letting it tip into control
When people talk about environmental factors with me for the first time, the same thing often happens. First comes relief, because somebody is finally listening. And then, a few weeks later, something else sometimes comes back.
A list. Thirty things that have to go. A shopping trip that takes an hour longer. An evening where, eating at friends' place, the question sits in your head about which container that was stored in.
That is not progress. That is shifting the problem.
Where effort and effectiveness match up
First: keep fat and flexible PVC apart. Hot fat does not belong in soft plastic. Do not heat food in plastic, do not pour warm fatty dishes into film or soft containers, prefer glass or metal for oil and fat. In the intervention study with fresh, unpackaged food the peak values of the DEHP metabolites fell by over 90 percent. Which part of the change produced that cannot be read out of the study. Going by the measurement data on fat and flexible PVC, this combination is the most plausible share of it, but it is not proven.
Second: reduce fragranced products rather than swapping them. The marker for diethyl phthalate reacts clearly to perfume and aftershave, and within 48 hours. Fewer product types counts for more here than a change of brand, because every additional product type was associated with plus 33 percent in the study. Honesty requires adding that this very phthalate has the weakest evidence in the antiandrogenic direction.
Third: damp mopping and airing out. In a home with old flexible PVC, a large part of the short chain phthalates comes from room air, mostly through the skin. Dry sweeping stirs up dust, damp mopping can bind it instead, and regular airing can lower the concentration in the gas phase. To be honest about it: these two habits are derived from the uptake pathways. I know of no study that measured whether mopping and airing lower the values in urine.
Fourth: be more consistent than usual during pregnancy and while trying to conceive. Not because everything is worse then, but because the data locate the most sensitive phase there. The same applies to the first years of life, because in German biomonitoring young children are the most heavily exposed group.
What I explicitly do not recommend
- A single phthalate measurement in urine as diagnostics. The value reflects one to two days. It tells you something about the day before yesterday, not about the last few years.
- Elimination programmes aimed at plasticizers. Going by everything the half lives show, there is no depot here that would need to be cleared. According to the available data the body excretes these substances within days, as soon as the intake falls.
- Measuring the anogenital distance in your own child. A research measure for group comparisons that says nothing about an individual child.
- Treating products advertised as phthalate free as the safe choice. Replacement substances are less well studied, and their levels in German biomonitoring are rising.
- Changing an ongoing medication because of this topic. The pill, hormone replacement therapy, antiandrogens or thyroid hormones are not adjusted, stopped or reduced on your own. If a prescription is on your mind, that belongs in a conversation with the doctor who issued it.
The paragraph that matters most to me
When caution tips into control, nothing has been gained.
I see this more often than I would like. A sensible change becomes a rule, the rule becomes a list, the list becomes a checking system. In the end there is a daily life in which food is no longer food but a risk decision. In people with a history of disordered eating, exactly that can set an old dynamic in motion again. If you notice that worry about ingredients is taking up more space than the food itself, it is worth looking at the article on eating disorders and the relationship between body and mind, and having a conversation with someone you trust.
There are free and confidential places to turn to, independent of any practice. In Germany the eating disorder helpline of the Federal Centre for Health Education can be reached on 0221 892031. In a mental health crisis, Telefonseelsorge is available around the clock on 0800 111 0 111 or 0800 111 0 222. If there is acute danger to you or to someone else, call the emergency number 112.
There is also a factual argument for this, not only a psychological one. The three intervention studies show that individual effort in this field can only be steered to a limited degree. In one of them the burden rose despite maximum care, because the study food itself was contaminated. The authors of the third study explicitly conclude that regulation in processing and packaging is a stronger lever than appeals to individuals.
Perfection here is not only exhausting. It is also not achievable. Two or three calm habits beat thirty nervous rules, and they last longer.
The usual word for environmental topics is avoid. Avoid is a yes or no word, and it invites failure, because complete avoidance is not possible.
I prefer to think in frequency. Not never, but less often. Not everything, but the two places where it counts.
That is not only kinder, it also fits the biology better. Because there is no depot, the daily resupply is what counts. And resupply is a question of habits, not of perfection.
What I actually ask in consultation
I ask about your job and whether you work with plastics, paints or adhesives. I ask about the age of your home and about the floor covering. I ask how often fragranced products are used. And I ask how food is prepared and stored, with a focus on warm and fatty dishes.
That is not diagnostics. That is history taking. And when I ask these questions, it is never about naming a cause. It is about completing the picture before anyone talks about causes.
Clinically I observe that many people have never heard the questions about their home before. What follows from that is open. There are no studies on this approach, and I am explicitly describing an observation here, not a documented method.
If a suspicion of exposure to metals comes up alongside this, that is a separate question with its own diagnostics, and you can read more under measuring heavy metals in blood or urine. For pregnancy and children there is a separate article on heavy metals in pregnancy and childhood.
None of this means that every hormonal disturbance has an environmental cause. The gynaecological and andrological assessment remains the foundation. The environmental perspective comes on top, not in its place. It is another window into the same room, and sometimes light falls through that window onto something that was in the shade before.
And now you know why I ask about packaging, fragrance and housing when hormonal complaints come up. Not because I believe the answer is there. Because in the short time of a routine consultation this question often finds no room, and because the cost of asking is low.
Frequently asked questions about phthalates
What are phthalates, explained in one sentence?
Phthalates are esters of phthalic acid that give rigid PVC its flexibility and serve as solvents and fragrance fixatives in cosmetics. They are not chemically bound to the plastic, they sit inside it like water in a sponge. That is why they migrate out over time, into air, dust, fat and skin.
Are phthalates xenoestrogens or not?
Based on the available literature, not in the classical sense. A xenoestrogen docks onto the estrogen receptor and mimics estrogen. Phthalates do something else: in animal models they lower testosterone production in the Leydig cell of the fetal testis. Neither DEHP nor its metabolite MEHP showed binding to the human androgen receptor up to 10 micromolar. So the best documented direction of action is antiandrogenic and it runs through hormone production, not through the receptor. The substance group is not entirely without an estrogenic signal: in cell assays BBP, DBP, DIBP, DEP and DINP showed a very weak estrogenic activity, roughly one million to fifty million times weaker than estradiol, while DEHP showed none and the monoester metabolites circulating in the body were inactive. That order of magnitude carries no statement about a person's hormone balance.
Then why does everyone say they disturb the estrogen balance?
Because endocrine disruptor is an umbrella term and not a mechanism. Substances with very different points of attack fall under it. When a text throws them all into one pot, the best known example, the estrogen mimic, accidentally becomes the rule. For phthalates that is imprecise and it points in the wrong direction, because the most sensitive phase is male development in the womb and not the menstrual cycle of an adult woman.
What is the difference between DEHP, DBP, BBP, DINP and DIDP?
It is a question of chain length. DBP, DIBP and BBP are short to medium chain, DEHP sits in the transition zone, DINP and DIDP are long chain. In 2019 EFSA grouped DBP, BBP, DEHP and DINP together and assigned them a joint limit of 50 micrograms per kilogram of body weight per day, explicitly because they share the same mode of action. DIDP was separated from that group and received its own value of 150, because there liver effects and not reproduction were decisive.
Are phthalates in perfume, and which ones?
The classic fragrance phthalate is diethyl phthalate, DEP for short. It keeps the scent on the skin for longer. In a study of 406 men, the urinary marker MEP in people who had used cologne or aftershave in the previous 48 hours had a median of 265 and 266 nanograms per millilitre respectively, compared with 108 and 133 in non users. For each additional product type used, MEP rose by 33 percent. Important for context: the systematic review by Radke and colleagues rates DEP as weak in the antiandrogenic direction.
Is there plasticizer in sunscreen?
It is possible, and only the declaration can tell you reliably. In cosmetics phthalates appear mainly as solvents and fragrance fixatives, and they often hide behind the collective term parfum or fragrance on the ingredient list. In the questionnaire study I am drawing on here, the use of lotions was actually associated with lower levels of MBP, MBzP and MEHP. Turning one product category into a rule is therefore not supported by the data.
What does phthalate free on a package actually mean?
It says something about one substance group, not about safety. Since the classic phthalates were regulated, replacement plasticizers have taken their place. German human biomonitoring shows exactly that: the burden from DEHP, DiBP, DnBP and BBzP has fallen clearly, while DPHP, DEHTP and DINCH have risen significantly. These substitutes are less well studied toxicologically. Phthalate free therefore means: this one circle of substances is out. It does not mean: there is nothing in here.
Do microplastics have the same hormonal effect as plasticizers?
These are two different topics that often get mixed up. Microplastics consist of particles. Phthalates are additives that migrate out of plastic as individual molecules. There are overlaps, because particles can carry additives with them. An equivalent hormonal effect is not documented in the sources reviewed here, and I would therefore not claim it either.
What is the anogenital distance, and should I worry about my baby?
The anogenital distance is a measurement between the anus and the genitals that research uses as a mirror of androgen action in the womb. In the TIDES cohort with 366 boys, the associations with three DEHP metabolites were around minus 1.1 to minus 1.4 millimetres. That is a population signal across hundreds of children and not a finding you could read off an individual child. Another cohort even found a longer distance for the DBP sum. Measuring at home makes no sense and would only create worry.
Can I have phthalates measured in urine, and what does that give me?
It can be measured, and what is measured are breakdown products in urine. The catch lies in the half life: it is hours to a few days. A single value therefore essentially reflects the last one to two days and not a burden over years. For research with repeated samples that is valuable, for an individual one off measurement the gain in knowledge is limited. What can sensibly be derived and what cannot is described in more detail in the article on hormone testing.
How quickly do phthalates leave the body again?
Very quickly compared with heavy metals or PFAS. Phthalates are metabolised rapidly and excreted through urine, the half lives are in the range of hours to a few days. So there is no depot in fatty tissue that fills up over years. What leads to high values is not storage but daily resupply.
Does switching to fresh unpackaged food help?
Sometimes clearly, sometimes not at all. In a study with five families the geometric means of the DEHP metabolites fell by 53 to 56 percent after three days of fresh food, the peak values by 93 to 96 percent. In a randomised study with ten families the same values rose sharply instead, because the provided study food was itself contaminated, among other things ground coriander at 21,400 nanograms per gram. In a pilot study with ten pregnant women nothing changed. The honest answer is therefore: the lever works where the source really is the packaging.
Have phthalate levels in Germany come down?
Yes, and that is the calmest finding of the whole topic. The German Environmental Specimen Bank analysed 1,162 twenty four hour urine samples from the years 1988 to 2015. For the metabolites of DEHP, DnBP and BBzP there was a roughly tenfold decline in median values from the peaks in the late eighties through to 2015. Before 2002, health based guidance values for DnBP were exceeded in 27.2 percent of samples, in more recent samples DEHP was still exceeded in 1.0 percent.
Are the substitutes such as DINCH and DEHTP safer?
Above all they are less well studied. The review by the German Environment Agency of German human biomonitoring describes how the substitutes mimic the exposure behaviour of the regulated phthalates: they rise exactly when the old ones fall. The data on their toxicology are thinner. A replacement substance is therefore first of all a replacement substance and not an all clear.
What matters most when trying to conceive and during pregnancy?
The data suggest that the most sensitive phase is development in the womb and not adult life. That is exactly why it makes sense to be somewhat more consistent about fat and flexible PVC during this time and to reduce fragranced products. The second sentence matters just as much: guilt is out of place here. Nobody can control an environment that is largely determined by processing, packaging and building materials. And gynaecological or andrological care remains the foundation, the environmental perspective comes on top.
Where this topic connects to the rest
Phthalates are one single circle of substances in a bigger picture. Depending on what brought you here, it continues in a different place.
Xenoestrogens in everyday life
The substances that really do act at the estrogen receptor, and how they differ from phthalates.
If it concerns you as a manXenoestrogens in men
Why the male hormone axis responds differently to environmental substances, and which markers count there.
If it is about trying to conceiveSemen quality and fertility
The article where the semen parameters are covered in detail. Here in the text they appeared in only two sentences.
If the value is already lowTestosterone deficiency in men
What belongs to be clarified before the environmental question, when a lab value is already below the reference range.
If the trend interests youTestosterone is falling worldwide
The population trend across generations, and which explanations are being discussed for it at all.
If mould is in the pictureZearalenone and hormones
The mycoestrogen that really does act at the estrogen receptor. For women often the closer trail.
If you want to start at breakdownEstrogen and the liver
How the body breaks estrogen down and why the detoxification pathways count in hormonal complaints.
If you want to know what is measurableHormone testing in women
Which test says something when, and why snapshots can be misleading for some parameters.
If you are thinking about testingMeasuring heavy metals
Blood or urine, snapshot or store. The comparison makes clear why phthalates are a different case.
If you are pregnantHeavy metals in pregnancy and childhood
The same logic of sensitive windows, applied to a completely different substance group.
If caution turns into compulsionUnderstanding eating disorders
For the point at which a sensible change starts to run your daily life instead of easing it.
If you are looking for the big pictureHormonal imbalance in women
The overview article from which this spoke picks out a single topic and goes deeper.
If you want the detail on the substanceBisphenol A and your hormones
The substance from tins and till receipts, the 2023 EFSA reassessment and what BPA free does and does not mean.
If you want to place drinking water and cookwarePFAS: the forever chemicals
Why the forever chemicals stay in the body for years and where individual avoidance reaches its limit.
If you are looking at the bathroom shelfEndocrine disruptors in cosmetics
Parabens, UV filters and fragrances, sorted by what is documented and what is merely loud.
If you want the whole pictureWhy I look for environmental factors
Why I look for environmental factors in hormonal symptoms, along which grid, and when that search adds nothing.
Scientific sources
- EFSA Panel on Food Contact Materials, Enzymes and Processing Aids (CEP). Update of the risk assessment of di-butylphthalate (DBP), butyl-benzyl-phthalate (BBP), bis(2-ethylhexyl)phthalate (DEHP), di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP) for use in food contact materials. EFSA Journal. 2019;17(12):e05838. DOI: 10.2903/j.efsa.2019.5838 [Agency Document, EFSA] [Guideline]
- Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, Toppari J, Zoeller RT. EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36(6):E1-E150. PMID: 26544531 · DOI: 10.1210/er.2015-1010 [Consensus Guideline, professional society] [Guideline]
- Commission Regulation (EU) 2018/2005 of 17 December 2018 amending Annex XVII to Regulation (EC) No 1907/2006 (REACH) as regards DEHP, DBP, BBP and DIBP, entry 51. Official Journal of the European Union. [Agency Document, EU legal act] [Guideline]
- Radke EG, Braun JM, Meeker JD, Cooper GS. Phthalate exposure and male reproductive outcomes: A systematic review of the human epidemiological evidence. Environ Int. 2018;121(Pt 1):764-793. PMID: 30336412 · DOI: 10.1016/j.envint.2018.07.029 [Systematic Review, human data]
- Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray LE. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci. 2000;58(2):339-349. PMID: 11099646 · DOI: 10.1093/toxsci/58.2.339 [In vivo, rat, in utero]
- Foster PMD. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl. 2006;29(1):140-147. PMID: 16102138 · DOI: 10.1111/j.1365-2605.2005.00563.x [Mechanism Review, rodent data]
- Harris CA, Henttu P, Parker MG, Sumpter JP. The estrogenic activity of phthalate esters in vitro. Environ Health Perspect. 1997;105(8):802-811. PMID: 9347895 · DOI: 10.1289/ehp.97105802 [In vitro, yeast screen and cell line]
- Desdoits-Lethimonier C, Albert O, Le Bizec B, Perdu E, Zalko D, Courant F, Lesné L, Guillé F, Dejucq-Rainsford N, Jégou B. Human testis steroidogenesis is inhibited by phthalates. Hum Reprod. 2012;27(5):1451-1459. PMID: 22402212 · DOI: 10.1093/humrep/des069 [In vitro, organ culture and cell line]
- Mitchell RT, Childs AJ, Anderson RA, van den Driesche S, Saunders PTK, McKinnell C, Wallace WHB, Kelnar CJH, Sharpe RM. Do phthalates affect steroidogenesis by the human fetal testis? Exposure of human fetal testis xenografts to di-n-butyl phthalate. J Clin Endocrinol Metab. 2012;97(3):E341-E348. PMID: 22238399 · DOI: 10.1210/jc.2011-2411 [In vivo, xenograft, n=12]
- Heger NE, Hall SJ, Sandrof MA, McDonnell EV, Hensley JB, McDowell EN, Martin KA, Gaido KW, Johnson KJ, Boekelheide K. Human fetal testis xenografts are resistant to phthalate-induced endocrine disruption. Environ Health Perspect. 2012;120(8):1137-1143. PMID: 22511013 · DOI: 10.1289/ehp.1104711 [In vivo, xenograft]
- Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, Mao CS, Redmon JB, Ternand CL, Sullivan S, Teague JL. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005;113(8):1056-1061. PMID: 16079079 · DOI: 10.1289/ehp.8100 [Cohort, newborns and infants]
- Swan SH, Sathyanarayana S, Barrett ES, Janssen S, Liu F, Nguyen RHN, Redmon JB (TIDES Study Team). First trimester phthalate exposure and anogenital distance in newborns. Hum Reprod. 2015;30(4):963-972. PMID: 25697839 · DOI: 10.1093/humrep/deu363 [Cohort, prospective, n=753]
- Wenzel AG, Bloom MS, Butts CD, Wineland RJ, Brock JW, Cruze L, Unal ER, Kucklick JR, Somerville SE, Newman RB. Influence of race on prenatal phthalate exposure and anogenital measurements among boys and girls. Environ Int. 2018;110:61-70. PMID: 29097052 · DOI: 10.1016/j.envint.2017.10.007 [Cohort, prospective]
- Meeker JD, Ferguson KK. Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011-2012. J Clin Endocrinol Metab. 2014;99(11):4346-4352. PMID: 25121464 · DOI: 10.1210/jc.2014-2555 [Cohort, cross section NHANES]
- Pan G, Hanaoka T, Yoshimura M, Zhang S, Wang P, Tsukino H, Inoue K, Nakazawa H, Tsugane S, Takahashi K. Decreased serum free testosterone in workers exposed to high levels of di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): a cross-sectional study in China. Environ Health Perspect. 2006;114(11):1643-1648. PMID: 17107847 · DOI: 10.1289/ehp.9016 [Cohort, cross section, occupational exposure]
- Hauser R, Meeker JD, Duty S, Silva MJ, Calafat AM. Altered semen quality in relation to urinary concentrations of phthalate monoester and oxidative metabolites. Epidemiology. 2006;17(6):682-691. PMID: 17003688 · DOI: 10.1097/01.ede.0000235996.89953.d7 [Cohort, clinic, subfertile couples]
- Welch BM, Keil AP, Buckley JP, Calafat AM, Christenbury KE, Engel SM, O'Brien KM, Rosen EM, James-Todd T, Zota AR, Ferguson KK. Associations Between Prenatal Urinary Biomarkers of Phthalate Exposure and Preterm Birth: A Pooled Study of 16 US Cohorts. JAMA Pediatr. 2022;176(9):895-905. PMID: 35816333 · DOI: 10.1001/jamapediatrics.2022.2252 [Cohort, pooled, n=6,045]
- Factor-Litvak P, Insel B, Calafat AM, Liu X, Perera F, Rauh VA, Whyatt RM. Persistent Associations between Maternal Prenatal Exposure to Phthalates on Child IQ at Age 7 Years. PLoS One. 2014;9(12):e114003. PMID: 25493564 · DOI: 10.1371/journal.pone.0114003 [Cohort, longitudinal]
- Messerlian C, Souter I, Gaskins AJ, Williams PL, Ford JB, Chiu YH, Calafat AM, Hauser R (EARTH Study Team). Urinary phthalate metabolites and ovarian reserve among women seeking infertility care. Hum Reprod. 2016;31(1):75-83. PMID: 26573529 · DOI: 10.1093/humrep/dev292 [Cohort, prospective, fertility centre]
- Stahlhut RW, van Wijngaarden E, Dye TD, Cook S, Swan SH. Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect. 2007;115(6):876-882. PMID: 17589594 · DOI: 10.1289/ehp.9882 [Cohort, cross section NHANES]
- Ding T, Yan W, Zhou T, Shen W, Wang T, Li M, Zhou S, Wu M, Dai J, Huang K, Zhang J, Chang J, Wang S. Endocrine disrupting chemicals impact on ovarian aging: Evidence from epidemiological and experimental evidence. Environ Pollut. 2022;305:119269. PMID: 35405219 · DOI: 10.1016/j.envpol.2022.119269 [Mechanism Review, human and animal data]
- Serrano SE, Braun J, Trasande L, Dills R, Sathyanarayana S. Phthalates and diet: a review of the food monitoring and epidemiology data. Environ Health. 2014;13(1):43. PMID: 24894065 · DOI: 10.1186/1476-069X-13-43 [Mechanism Review, food monitoring]
- Duty SM, Ackerman RM, Calafat AM, Hauser R. Personal care product use predicts urinary concentrations of some phthalate monoesters. Environ Health Perspect. 2005;113(11):1530-1535. PMID: 16263507 · DOI: 10.1289/ehp.8083 [Cohort, cross section with questionnaire]
- Bekö G, Weschler CJ, Langer S, Callesen M, Toftum J, Clausen G. Children's phthalate intakes and resultant cumulative exposures estimated from urine compared with estimates from dust ingestion, inhalation and dermal absorption in their homes and daycare centers. PLoS One. 2013;8(4):e62442. PMID: 23626820 · DOI: 10.1371/journal.pone.0062442 [Cohort, biomonitoring and modelling]
- Pinguet J, Kerckhove N, Eljezi T, Lambert C, Moreau E, Bernard L, Boeuf B, Decaudin B, Genay S, Masse M, Storme L, Sautou V, Richard D. New SPE-LC-MS/MS method for the simultaneous determination in urine of 22 metabolites of DEHP and alternative plasticizers from PVC medical devices. Talanta. 2019;198:377-389. PMID: 30876575 · DOI: 10.1016/j.talanta.2019.01.115 [Cohort, biomonitoring, neonatology]
- Rudel RA, Gray JM, Engel CL, Rawsthorne TW, Dodson RE, Ackerman JM, Rizzo J, Nudelman JL, Brody JG. Food packaging and bisphenol A and bis(2-ethyhexyl) phthalate exposure: findings from a dietary intervention. Environ Health Perspect. 2011;119(7):914-920. PMID: 21450549 · DOI: 10.1289/ehp.1003170 [Intervention, n=20, no control arm]
- Sathyanarayana S, Alcedo G, Saelens BE, Zhou C, Dills RL, Yu J, Lanphear B. Unexpected results in a randomized dietary trial to reduce phthalate and bisphenol A exposures. J Expo Sci Environ Epidemiol. 2013;23(4):378-384. PMID: 23443238 · DOI: 10.1038/jes.2013.9 [RCT, n=10 families]
- Barrett ES, Velez M, Qiu X, Chen SR. Reducing Prenatal Phthalate Exposure Through Maternal Dietary Changes: Results from a Pilot Study. Matern Child Health J. 2015;19(9):1936-1942. PMID: 25652062 · DOI: 10.1007/s10995-015-1707-0 [Intervention, pilot study, n=10]
- Koch HM, Rüther M, Schütze A, Conrad A, Pälmke C, Apel P, Brüning T, Kolossa-Gehring M. Phthalate metabolites in 24-h urine samples of the German Environmental Specimen Bank (ESB) from 1988 to 2015 and a comparison with US NHANES data from 1999 to 2012. Int J Hyg Environ Health. 2017;220(2 Pt A):130-141. PMID: 27863804 · DOI: 10.1016/j.ijheh.2016.11.003 [Cohort, biomonitoring time series, n=1,162]
- Lemke N, Murawski A, Lange R, Weber T, Apel P, Debiak M, Koch HM, Kolossa-Gehring M. Substitutes mimic the exposure behaviour of REACH regulated phthalates. A review of the German HBM system on the example of plasticizers. Int J Hyg Environ Health. 2021;236:113780. PMID: 34126298 · DOI: 10.1016/j.ijheh.2021.113780 [Agency Document, German Environment Agency]
- The mechanism comes from the animal model. The reduction of fetal testosterone production is well documented in the rat, at doses of 750 milligrams per kilogram per day. Estimated dietary intake in humans according to EFSA is several orders of magnitude below that.
- The transfer to humans is open. Two independent studies found no suppression of steroidogenesis in human fetal testis tissue as a xenograft, although rat tissue reacted in the same model. In adult human testis explants, by contrast, inhibition was seen. The text words this as an open species question, because there is no closed answer.
- The human data are observational data. Cohorts and cross sections can show associations, not causes. The effect sizes are small, several confidence intervals touch one, and the estimate of prevented preterm births comes from a model calculation with causal assumptions.
- The direction is not the same everywhere. For the DBP sum, one cohort found a longer anoscrotal distance, not a shorter one. For the three DEHP metabolites, the largest semen quality cohort found no association, although DEHP is rated robust overall.
- Dose response relationships are not always rising. In the study on ovarian reserve the strongest association was in the second quartile, not in the highest. The Endocrine Society statement explicitly describes non monotonic curves as a principle of endocrine disruptors.
- The intervention data contradict each other. One study showed a clear reduction, a randomised study a sharp rise because of contaminated study food, a pilot study in pregnant women no change at all. The practical part is worded cautiously accordingly.
- What I observe clinically is labelled as an observation. The environmental history in hormonal complaints is my way of working. There are no studies testing this approach.
- On the legal act. Annex XVII of the REACH regulation is amended continuously. The limits and deadlines named here refer to entry 51 in the version of Regulation (EU) 2018/2005. For legally binding information, the current consolidated version applies.
- Not used. The figure of 22 percent less testosterone that circulates online could not be traced to any publication with a PMID and is therefore not cited. The claim that phthalates act at the estrogen receptor is not left out but placed in scale: it goes back to cell assays in which individual phthalates showed an estrogenic activity roughly a million times weaker than estradiol, while DEHP showed none at all and the monoester metabolites that circulate in humans were inactive (Harris 1997). As a description of a relevant direction of action in humans this finding does not hold.
- Status. Research and cross verification of the 30 sources on 25 August 2026 via PubMed and Crossref. This article is information and not individual medical advice.